• Systemic mycoses are not usually treated primarily by dermatologists.
• Most opportunistic mycoses are seen in immunocompromised patients.
• Skin lesions in most endemic mycoses such as paracoccidioidomycosis probably result from lung dissemination.
• They occasionally exhibit direct skin invasion following infiltration of organisms or indirect skin manifestations such as erythema nodosum or multiforme, probably from immune complex deposition.
• Although many patients with cutaneous cryptococcal infection probably develop skin involvement as a result from internal spread, some cases of primary cutaneous cryptococcus do exist.
• Anecdotal evidence suggests that itraconazole or fluconazole might be effective in such cases.
• A number of controlled clinical trials for the treatment of systemic mycoses are currently underway by the US Mycosis Study Group and the EORTC.
Was this article helpful?
Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.